Cancer Institute A national cancer institute
designated cancer center
Cancer Clinical Trials Office

IND Seminar Series

Sponsored by the Canary Center at Stanford for Cancer Early Detection and the Stanford Cancer Center Clinical Trials Office

The series is designed to cover the logistics and the process of IND (and Exploratory IND) filing, the regulatory strategy required for IND approvals, and successful communications with the FDA. Attendees will learn tools and resources from experienced regulatory professionals that are necessary for filing IND submissions with the FDA.

Target Audience: Cancer institute members and faculty researchers in the Molecular Imaging Program at Stanford.

Schedule

All Sessions 4:30 - 5:30 PM

Sem 1 Clark Ctr Aud
Clark Ctr Aud
Clark Ctr Aud
Clark Ctr Aud
LKSC Rm LK130
LKSC RM LK130
Clark Ctr Aud
     

Seminars:

Every seminar will include case studies and an overview of available resources.

Presenters Include:

For questions please contact:

 

Lee Doherty, Ed.M.
Regulatory Manager 
Stanford Cancer Institute
Clinical Trials Office
Tel:  650-736-0176
lee.doherty@stanford.edu

Daniela Starcevic, Ph.D.
Deputy Director
Canary Center at Stanford
for Cancer Early Detection
Tel: 650-724-6059
dstar25@stanford.edu

 

 

 

Stanford Medicine Resources:

Footer Links: